(Update: On November 4, 2021, the NIH provided a response to our comments on the license.) On October 12, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the ““Prospective Grant of an Exclusive… Continue Reading →
(For more resources, please see our page on molnupiravir.) Knowledge Ecology International (KEI) has obtained a copy of the $1.2 billion contract between the U.S. government and Merck to advance purchase 1,696,629 treatment courses of molnupiravir, an investigational COVID-19 drug… Continue Reading →
The US Federal Register has published a final rule for the “Concrete Masonry Products Research, Education, and Promotion Order.” (Link). The rule is being issued pursuant to Public Law 115-254, the FAA Reauthorization Act of 2018, which is described as… Continue Reading →
Spinal muscular atrophy (SMA) is a rare neuromuscular disorder, with an estimated incidence of between one and two cases per 10,000 births worldwide. The most severe form of the disease – SMA Type I – previously had close to 95%… Continue Reading →
On 12 May 2021, Antigua and Barbuda notified the World Trade Organization (WTO) of their general intent to use the compulsory license system provided under article 31bis of the amended Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This… Continue Reading →
MacDonald-Dupuis, Natasha. La Bolivie veut importer du Canada des vaccins contre la COVID-19. ICI Ontario. June 9, 2021. MacDonald-Dupuis, Natasha. La Bolivie veut importer du Canada des vaccins contre la COVID-19 Radio Canada. June 8, 2021. Bruce, Francesca. Canadian Firm… Continue Reading →
At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies on Thursday, 27 May 2021. Non-state… Continue Reading →
HouseOversight-UnsustainableDrugPrices-PartIII-2021 May 19, 2021 Rep. Carolyn B. Maloney Chairwoman of the Committee on Oversight and Reform U.S. House of Representatives Rep. James Comer Ranking Member of the Committee on Oversight and Reform U.S. House of Representatives Re: Request for statement… Continue Reading →
On May 18th, the People’s Vaccine Alliance sent Justin Trudeau, Prime Minister of Canada, a letter urgently requesting that vaccines, therapeutics and diagnostics for COVID-19 be added to Schedule 1 of the Patent Act. Below is the text of the PVA… Continue Reading →
On Monday, 17 May 2021, the 62 co-sponsors of a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19 (IP/C/W/669) published a joint statement (IP/C/W/677) on COVID-19. This joint statement foreshadows the revised… Continue Reading →